Xcout Intel
Pathos AI, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Pathos AI, Inc. among ai/ml companies — ranked by similarity to what Pathos AI, Inc. actually does, not by market-cap band.
Subscribe to see Pathos AI, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Pathos AI, Inc.
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Pathos AI, Inc. at a glance
Pathos AI, Inc. is an ai/ml company headquartered in United States. Its most recent funding round, Series D, raised $365M in May 2025. Xcout tracks 33 named people at Pathos AI, Inc., including Iker Huerga (CEO). Xcout recorded 4 job postings from Pathos AI, Inc. in the last 90 days.
Pathos AI, Inc. leadership
- Iker HuergaCEO
- Ryan FukushimaChief Executive Officer
- Matt De SilvaCHIEF OPERATING OFFICER
- Eric SchadtCHIEF SCIENCE OFFICER
- Mark FereshtehChief Scientific Officer
- Steve KyeChief Development lead
27 more named people on record for Pathos AI, Inc., with roles, board committees and tenure — see the full roster →
Pathos AI, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $365M | — | |
| SEC Form D filing | $62M | — | |
| Series C | $62M | 1 named | |
| SEC Form D filing | $20M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Pathos AI, Inc.
Xcout recorded 4 job postings from Pathos AI, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Pathos AI, Inc.'s hiring signals →
Top 12 Pathos AI, Inc. competitors
Ranked by semantic similarity — how close each company is to Pathos AI, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
AI-driven Drug Discovery
TenAces Biosciences is an Israel-based biopharmaceutical company and AION Labs startup that develops molecular glue therapeutics. The company utilizes machine learning and an AI platform to identify protein interactions and discover new molecular glue therapies.
AI-driven Drug Discovery
Cellyrix Therapeutics is a biotechnology company founded in 2024 and headquartered in Rehovot, Israel. The company leverages single-cell RNA sequencing and artificial intelligence to develop cancer treatments by addressing tumor heterogeneity and cell-state modulation.
Similar ai/ml company
PostEra Inc. is a U.S.-based biotechnology company that develops machine-learning and computational chemistry software for drug discovery and medicinal chemistry. Its platform helps pharmaceutical and biotechnology organizations design, prioritize, and manage experiments for small-molecule therapeutics.
Artificial Intelligence & Biotechnology
Latent Labs Technologies operates as a frontier artificial intelligence laboratory that builds generative models for molecular biology. The company provides AI-driven tools and agents—such as Latent-Y, Latent-X2, and Latent-X—to help researchers and partners design drugs, create antibodies, optimize enzymes, and advance genetic engineering.
Biotech, AI/ML
Pepticom operates an artificial intelligence-driven drug discovery platform focused on designing and optimizing novel therapeutic peptides. The company utilizes reinforcement learning, generative AI, and computational algorithms to develop drug candidates for both internal programs and industry collaborations.
Similar ai/ml company
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
Similar ai/ml company
Ataraxis AI is an artificial intelligence company headquartered in New York that links AI model predictions to real patient outcomes across oncology.
Biotech, AI/ML
Pangea Biomed, founded in 2018 and headquartered in Tel Aviv, Israel, is a biotechnology company focused on cancer. Its mission is to democratize precision oncology, bringing deep tumor intelligence to drug development and treatment nomination.
AI/ML (Drug Discovery)
ONCOCROSS Co., Ltd. is a public company headquartered in Seoul, South Korea. The company specializes in AI-driven drug discovery, focusing on making drugs work effectively.
AI Diagnostics, Drug Discovery
Headquartered in London, United Kingdom, Case 45 is an AI-based biotechnology business focused on tumor-infiltrating lymphocytes and cancer assessment.
Artificial Intelligence
StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics using its Polaris discovery platform. The company is headquartered in Berlin, Germany.
AI Technologies, Computational Science, Drug Discovery, Biotechnology
AION Labs is a venture studio headquartered in Rehovot, Israel. It is dedicated to building and investing in startups that leverage AI to revolutionize drug discovery and development, connecting pharma R&D with new AI, technology, and scientific innovation.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Pathos AI, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Pathos AI, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →